UK's MHRA approves GSL switch for allergy test

1 August 2019 - Deborah Wilkes

Archived

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has given the go-ahead for a skin patch that screens for allergies to paraphenylenediamine (PPD) – a common component of hair colourants – to be switched from a prescription-only medicine to general-sale list (GSL) status.

Click tags below for more information on topics:

MHRA

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: